You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,771,624


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,771,624 protect, and when does it expire?

Patent 11,771,624 protects POSIMIR and is included in one NDA.

This patent has seven patent family members in seven countries.


Drugs Protected by US Patent 11,771,624

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Innocoll POSIMIR bupivacaine SOLUTION;INFILTRATION 204803-001 Feb 1, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TO PRODUCE POST-SURGICAL ANALGESIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,771,624

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112022013784 ⤷  Subscribe
Canada 3167217 ⤷  Subscribe
China 115666621 ⤷  Subscribe
European Patent Office 4090353 ⤷  Subscribe
Japan 2023515918 ⤷  Subscribe
South Korea 20220140711 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2021146215 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.